Standard BioTools Inc (LAB)
2.44
+0.08
(+3.39%)
USD |
NASDAQ |
Apr 26, 16:00
2.435
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Enterprise Value: 656.51M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 656.51M |
| April 25, 2024 | 633.30M |
| April 24, 2024 | 650.70M |
| April 23, 2024 | 691.32M |
| April 22, 2024 | 685.52M |
| April 19, 2024 | 679.72M |
| April 18, 2024 | 685.52M |
| April 17, 2024 | 705.83M |
| April 16, 2024 | 734.84M |
| April 15, 2024 | 752.24M |
| April 12, 2024 | 758.05M |
| April 11, 2024 | 792.86M |
| April 10, 2024 | 772.55M |
| April 09, 2024 | 795.76M |
| April 08, 2024 | 784.16M |
| April 05, 2024 | 743.54M |
| April 04, 2024 | 717.43M |
| April 03, 2024 | 720.33M |
| April 02, 2024 | 714.53M |
| April 01, 2024 | 731.94M |
| March 28, 2024 | 734.84M |
| March 27, 2024 | 729.04M |
| March 26, 2024 | 714.53M |
| March 25, 2024 | 731.94M |
| March 22, 2024 | 726.13M |
| Date | Value |
|---|---|
| March 21, 2024 | 731.94M |
| March 20, 2024 | 708.73M |
| March 19, 2024 | 688.42M |
| March 18, 2024 | 700.02M |
| March 15, 2024 | 708.73M |
| March 14, 2024 | 694.22M |
| March 13, 2024 | 711.63M |
| March 12, 2024 | 726.13M |
| March 11, 2024 | 746.44M |
| March 08, 2024 | 755.15M |
| March 07, 2024 | 743.54M |
| March 06, 2024 | 702.92M |
| March 05, 2024 | 697.12M |
| March 04, 2024 | 697.12M |
| March 01, 2024 | 673.91M |
| February 29, 2024 | 601.38M |
| February 28, 2024 | 636.20M |
| February 27, 2024 | 627.49M |
| February 26, 2024 | 639.10M |
| February 23, 2024 | 659.41M |
| February 22, 2024 | 630.40M |
| February 21, 2024 | 644.90M |
| February 20, 2024 | 673.14M |
| February 16, 2024 | 693.43M |
| February 15, 2024 | 673.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-57.79M
Minimum
Sep 29 2022
952.66M
Maximum
Jun 05 2019
311.93M
Average
308.74M
Median
Feb 07 2022
Enterprise Value Benchmarks
| Bruker Corp | 11.98B |
| Azenta Inc | 1.926B |
| Harvard Bioscience Inc | 189.39M |
| Bionano Genomics Inc | 16.05M |
| Akoya Biosciences Inc | 178.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.78M |
| Revenue (Quarterly) | 28.19M |
| Total Expenses (Quarterly) | 43.09M |
| EPS Diluted (Quarterly) | -0.25 |
| Gross Profit Margin (Quarterly) | 47.39% |
| Profit Margin (Quarterly) | -70.16% |
| Earnings Yield | -38.93% |
| Normalized Earnings Yield | -33.20 |